Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024

Horizons: Perspectives on Psychedelics Conference Convenes in New York City

May 7, 2024

Lykos Adds to Executive Team as it Ramps for Potential Launch of MDMA-Assisted Therapy

May 6, 2024

Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm

April 26, 2024

Lykos Completes European Phase 2 Study for MDMA-Assisted Therapy

April 24, 2024

Numinus Plans to Refocus on U.S. Market, Considers Divesting Canadian Operations

April 18, 2024